Bioatla Company Insiders

BCAB Stock  USD 0.50  0.01  2.63%   
Bioatla's insiders are aggressively buying. The analysis of the overall insider sentiment regarding Bioatla suggests that all insiders are extremely bullish. Bioatla employs about 65 people. The company is managed by 15 executives with a total tenure of roughly 152 years, averaging almost 10.0 years of service per executive, having 4.33 employees per reported executive.

Bioatla's Insider Buying Vs Selling

100

 
Selling
 
Buying

Latest Trades

2023-12-26Sylvia McbrinnAcquired 4000 @ 2.33View
2023-12-20Jay M Phd ShortAcquired 50000 @ 2.14View
2023-12-19Lawrence SteinmanAcquired 20000 @ 2.05View
2023-09-08Sylvia McbrinnAcquired 2000 @ 2.54View
2023-03-29Jay M Phd ShortAcquired 40800 @ 2.47View
2023-03-28Christian VasquezAcquired 20000 @ 2.4View
2022-12-19Sylvia McbrinnAcquired 3700 @ 8.33View
2022-11-22Sylvia McbrinnAcquired 2000 @ 8.27View
2022-09-12Sylvia McbrinnAcquired 2000 @ 8.85View
2022-08-12Jay M Phd ShortAcquired 26350 @ 7.84View
2022-06-21Jay M Phd ShortAcquired 29082 @ 2.79View
2022-06-09Christian VasquezAcquired 10000 @ 2.97View
2022-06-07Christian VasquezAcquired 14152 @ 3.04View
Monitoring Bioatla's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bioatla. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
For information on how to trade Bioatla Stock refer to our How to Trade Bioatla Stock guide.

Bioatla Management Team Effectiveness

The company has return on total asset (ROA) of (0.5047) % which means that it has lost $0.5047 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.3906) %, meaning that it created substantial loss on money invested by shareholders. Bioatla's management efficiency ratios could be used to measure how well Bioatla manages its routine affairs as well as how well it operates its assets and liabilities. As of January 24, 2025, Return On Tangible Assets is expected to decline to -0.98. The current year's Return On Capital Employed is expected to grow to -1.21. At present, Bioatla's Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Net Tangible Assets is expected to grow to about 217.8 M, whereas Non Currrent Assets Other are forecasted to decline to about 158.9 K.
As of January 24, 2025, Common Stock Shares Outstanding is expected to decline to about 38.5 M. The current year's Net Loss is expected to grow to about (91 M)

Bioatla Workforce Comparison

Bioatla is rated below average in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 2,439. Bioatla holds roughly 65.0 in number of employees claiming about 2.67% of equities under Health Care industry.

Bioatla Insider Trading

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Bioatla insiders, such as employees or executives, is commonly permitted as long as it does not rely on Bioatla's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Bioatla insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Bioatla Notable Stakeholders

A Bioatla stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Bioatla often face trade-offs trying to please all of them. Bioatla's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Bioatla's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Gerhard FreySenior DevelopmentProfile
Cathy ChangSenior DevelopmentProfile
Christian CPAController OfficerProfile
Sheri LydickChief OfficerProfile
Philippe MartinChief OperationsProfile
Monica SullivanSenior ContractsProfile
Christian VasquezController OfficerProfile
Lisa PeltonAccounting ManagerProfile
Scott SmithPres DirectorProfile
Susie MelodySenior ResourcesProfile
Jay ShortCEO CoFounderProfile
Eric MDChief OfficerProfile
Richard WaldronChief OfficerProfile
Bin ZhangSenior DevelopmentProfile
MSc MDSenior DevelopmentProfile

About Bioatla Management Performance

The success or failure of an entity such as Bioatla often depends on how effective the management is. Bioatla management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Bioatla management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Bioatla management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last ReportedProjected for Next Year
Return On Tangible Assets(0.93)(0.98)
Return On Capital Employed(1.28)(1.21)
Return On Assets(0.93)(0.98)
Return On Equity(2.01)(1.91)
Please note, the presentation of Bioatla's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Bioatla's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Bioatla's management manipulating its earnings.

Bioatla Workforce Analysis

Traditionally, organizations such as Bioatla use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Bioatla within its industry.

Bioatla Manpower Efficiency

Return on Bioatla Manpower

Revenue Per Employee0.0
Revenue Per Executive0.0
Net Loss Per Employee1.9M
Net Loss Per Executive8.2M
Working Capital Per Employee1.4M
Working Capital Per Executive5.9M

Complementary Tools for Bioatla Stock analysis

When running Bioatla's price analysis, check to measure Bioatla's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bioatla is operating at the current time. Most of Bioatla's value examination focuses on studying past and present price action to predict the probability of Bioatla's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bioatla's price. Additionally, you may evaluate how the addition of Bioatla to your portfolios can decrease your overall portfolio volatility.
Global Correlations
Find global opportunities by holding instruments from different markets
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Bonds Directory
Find actively traded corporate debentures issued by US companies
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
FinTech Suite
Use AI to screen and filter profitable investment opportunities
CEOs Directory
Screen CEOs from public companies around the world